Paolo Corradini

1955–2026 年に発表

193
論文数
24,533
被引用数
88
h 指数
180
i10 指数

被引用数

Paolo Corradini の年別被引用数1948 年: 被引用 2 件1955 年: 被引用 1 件1956 年: 被引用 1 件1959 年: 被引用 2 件1960 年: 被引用 2 件1964 年: 被引用 2 件1980 年: 被引用 2 件1981 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 1 件1987 年: 被引用 1 件1988 年: 被引用 2 件1989 年: 被引用 3 件1990 年: 被引用 2 件1991 年: 被引用 1 件1992 年: 被引用 14 件1993 年: 被引用 34 件1994 年: 被引用 36 件1995 年: 被引用 35 件1996 年: 被引用 36 件1997 年: 被引用 35 件1998 年: 被引用 42 件1999 年: 被引用 49 件2000 年: 被引用 71 件2001 年: 被引用 49 件2002 年: 被引用 65 件2003 年: 被引用 72 件2004 年: 被引用 49 件2005 年: 被引用 50 件2006 年: 被引用 48 件2007 年: 被引用 68 件2008 年: 被引用 85 件2009 年: 被引用 86 件2010 年: 被引用 109 件2011 年: 被引用 121 件2012 年: 被引用 100 件2013 年: 被引用 91 件2014 年: 被引用 99 件2015 年: 被引用 127 件2016 年: 被引用 121 件2017 年: 被引用 145 件2018 年: 被引用 101 件2019 年: 被引用 485 件2020 年: 被引用 644 件2021 年: 被引用 711 件2022 年: 被引用 680 件2023 年: 被引用 567 件2024 年: 被引用 963 件2025 年: 被引用 438 件2026 年: 被引用 6 件1949〜1954 年は被引用が無いため表示していません1957〜1958 年は被引用が無いため表示していません1961〜1963 年は被引用が無いため表示していません1965〜1979 年は被引用が無いため表示していません1982〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,373 件、この内訳の 21.8%イタリア: 引用元論文 970 件、この内訳の 8.9%ドイツ: 引用元論文 816 件、この内訳の 7.5%イギリス: 引用元論文 674 件、この内訳の 6.2%フランス: 引用元論文 660 件、この内訳の 6.1%スペイン: 引用元論文 582 件、この内訳の 5.4%中国: 引用元論文 397 件、この内訳の 3.7%オランダ: 引用元論文 376 件、この内訳の 3.5%カナダ: 引用元論文 363 件、この内訳の 3.3%オーストラリア: 引用元論文 279 件、この内訳の 2.6%スイス: 引用元論文 274 件、この内訳の 2.5%日本: 引用元論文 248 件、この内訳の 2.3%
0%21.8%その他 26.2%

分野

  • Medicine83.4%
  • Biochemistry, Genetics and Molecular Biology9.7%
  • Immunology and Microbiology3.7%
  • Chemistry1.3%
  • Materials Science0.6%
  • Chemical Engineering0.2%
  • その他1.1%

トピック

  • Multiple Myeloma Research and Treatments10.6%
  • CAR-T cell therapy research7%
  • Lymphoma Diagnosis and Treatment7%
  • Protein Degradation and Inhibitors5.5%
  • Chronic Lymphocytic Leukemia Research3.6%
  • Hematopoietic Stem Cell Transplantation3.3%
  • その他63%

共著者

全論文

検索で開く
  1. Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 676

  2. Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 561

  3. Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Thiéblemont, Max S. Topp, Pier Luigi Zinzani, John G. Gribben, Chiara Bonini, Anna Sureda, Ibrahim Yakoub‐Agha - Blood 2023 被引用: 311

  4. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Simon J. Harrison, Wojciech Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard LeBlanc, Michel Pavic, Michaël Sébag, Roman Hájek, Vladimír Maisnar, Luděk Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre‐Barbe, Thierry Façon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourié, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Αchilles Anagnostopoulos, Sosana Delimpasi, Marie‐Christine Kyrtsonis, Anargyros Symeonidis, Árpád Illés, Gábor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Fabio Ciceri, Roberto M. Lemoli, Anna Marina Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kım, Jae Hoon Lee, Chang‐Ki Min, Hillary Blacklock, Hugh J. B. Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn ほか 30 名 - The Lancet 2019 被引用: 636

  5. Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 244

  6. Genomic landscape and chronological reconstruction of driver events in multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 被引用: 273

  7. RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tom Moore, Meike Schneider, Wolfgang Jacob, Maja Weisser, Martin Hutchings, Caroline Hasselbalch Riley - Blood 2022 被引用: 90

  8. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Javier de la Rubia, Peter Gimsing, Sagar Lonial, Jonathan L. Kaufman, Enrique M. Ocio, Ljupco Veskovski, Sang Kyun Sohn, Ming-Chung Wang, Jae Hoon Lee, Hermann Einsele, Monika Sopala, Claudia Corrado, B. Bengoudifa, Florence Binlich, Paul G. Richardson - The Lancet Oncology 2014 被引用: 788

  9. Timing the initiation of multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 163

  10. High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 88

  11. Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma

    著者: , , , , , , , , , , , , , - Clinical Cancer Research 2022 被引用: 64

  12. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicola Fracchiolla, Austin Kulasekararaj, Toni Valković, Christian Bjørn Poulsen, Marina Machado, Andreas Glenthøj, И. О. Стома, Zdeněk Ráčil, Klára Piukovics, Milan Navrátil, Ziad Emarah, Uluhan Sili, Johan Maertens, Ola Blennow, Rui Bergantim, Carolina García‐Vidal, Lucia Prezioso, Anna Guidetti, Maria Ilaria Del Principe, Marina Popova, Nick de Jonge, Irati Ormazabal‐Vélez, Noemí Fernández, Iker Falces‐Romero, Annarosa Cuccaro, Stef Meers, Caterina Buquicchio, Darko Antić, Murtadha Al‐Khabori, Ramón García‐Sánz, Monika Biernat, Maria Chiara Tisi, Ertan Sal, Laman Rahimli, Nataša Čolović, Martin Schönlein, María Calbacho, Carlo Tascini, Carolina Miranda, Nina Khanna, Gustavo‐Adolfo Méndez, Verena Petzer, Jan Novák, Caroline Besson, Rémy Duléry, Sylvain Lamure, Márcio Nucci, Giovanni Paolo Maria Zambrotta, Павел Зак, Güldane Cengiz Seval, Valentina Bonuomo, Jiřı́ Mayer, Alberto López‐García, Maria Vittoria Sacchi, Stephen Booth, Fabio Ciceri, Margherita Oberti, Marco Salvini, Macarena Izuzquiza, Raquel Nunes Rodrigues, Emanuele Ammatuna, Aleš Obr, Raoul Herbrecht, Lucía Núñez-Martín-Buitrago, Valentina Mancini, Hawraa Shwaylia, Mariarita Sciumé, Jenna Essame, Marietta Nygaard, Josip Batinić ほか 96 名 - Journal of Hematology & Oncology 2021 被引用: 318

  13. Genomic patterns of progression in smoldering multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 被引用: 220

  14. Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2022 被引用: 85

  15. Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 781

  16. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2018 被引用: 191

  17. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2017 被引用: 121

  18. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrizia Tosi, Francesco Lanza, Massimo Massaia, Mauro Turrini, Felicetto Ferrara, Carmela Gurrieri, Daniele Vallisa, Maurizio Martelli, Enrico Derenzini, Attilio Guarini, Annarita Conconi, Annarosa Cuccaro, Laura Cudillo, Domenico Russo, Fabrizio Ciambelli, Anna Maria Scattolin, Mario Luppi, Carmine Selleri, Elettra Ortu La Barbera, Celestino Ferrandina, Nicola Di Renzo, Attilio Olivieri, Monica Bocchia, Massimo Gentile, Francesco Marchesi, Pellegrino Musto, Augusto B. Federici, Anna Candoni, Adriano Venditti, Carmen Fava, Antonio Pinto, Piero Galieni, Luigi Rigacci, Daniele Armiento, Fabrizio Pane, Margherita Oberti, Patrizia Zappasodi, Carlo Visco, Matteo Franchi, Paolo Grossi, Lorenza Bertù, Giovanni Corrao, Livio Pagano, Paolo Corradini - The Lancet Haematology 2020 被引用: 554

  19. Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR

    著者: , , , , , , , , , , , , , , , , - Clinical Lymphoma Myeloma & Leukemia 2019 被引用: 153

  20. CAMMA 2: A phase I/II trial evaluating the efficacy and safety of cevostamab in patients with relapsed/refractory multiple myeloma (RRMM) who have triple-class refractory disease and have received a prior anti-B-cell maturation antigen (BCMA) agent.

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 40

  21. Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2023 被引用: 36

  22. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2009 被引用: 394

  23. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesca Bonifazi, Alessandro Rambaldi, Saveria Capria, Alice Bertaina, Angela Mastronuzzi, Daria Pagliara, Paola Bernaschi, Lucia Amico, Alessandra Carotti, Antonella Mencacci, Alessandro Busca, Benedetto Bruno, Cristina Costa, Angela Passi, G Ravizzola, Emanuele Angelucci, Anna Marchese, Patrizia Pecile, Anna Candoni, Giovanna Ventura, Renato Fanin, Claudio Scarparo, Angelo Pasquale Barbaro, Giuseppe Milone, Salvatore Leotta, Anna Marchese, G. Marcacci, Cristina Becchimanzi, Daniela Donnarumma, Stefania Tringali, Maria Teresa Baldi, Renato Scalone, Maria Teresa Baldi, Laura Cudillo, Alessandra Picardi, William Arcese, Carla Fontana, Simona Sica, Sabrina Giammarco, Teresa Spanu, Luca Castagna, Roberto Crocchiolo, Erminia Casari, Paolo Corradini, Alberto Mussetti, Eutilia Conte, Fabrizio Ensoli, G. Miragliotta, P. Marone, Milena Arghittu, Raffaella Greco, Alessandra Forcina, Paola Chichero, Stella Santarone, Paolo Di Bartolomeo, Paolo Fazii, Vesselina Kroumova, Nunzia Decembrino, Marco Zecca, P. Marone, Giovanni Pisapia, Giulia Palazzo, Giulia Palazzo, Edoardo Lanino, Maura Faraci, Elio Castagnola, Roberto Bandettini, Rocco Pastano, Simona Sammassimo, Rita Passerini ほか 73 名 - Clinical Infectious Diseases 2017 被引用: 160

  24. Genetic and phenotypic attributes of splenic marginal zone lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Enrico Derenzini, Liliana Devizzi, Sascha Dietrich, Angela Rita Elia, Fabio Facchetti, Gianluca Gaïdano, Juan F. Garcı́a, B. Gerber, Paolo Ghia, María Gomes da Silva, Giuseppe Gritti, Anna Guidetti, Felicitas Hitz, Giorgio Inghirami, Marco Ladetto, Armando López‐Guillermo, Elisa Lucchini, Antonino Maiorana, Roberto Marasca, Estella Matutes, Véronique Meignin, Michele Merli, Alden A. Moccia, Manuela Mollejo, Carlos Montalbán, Urban Novak, David Oscier, Francesco Passamonti, Francesco Piazza, Stefano Pizzolitto, Alessandro Rambaldi, Elena Sabattini, Gilles Salles, Elisa Santambrogio, Lydia Scarfò, Anastasios Stathis, Georg Stüssi, Julia T. Geyer, Gustavo Tapia, Corrado Tarella, Catherine Thiéblemont, Thomas Tousseyn, Alessandra Tucci, Giorgio Vanini, Carlo Visco, Umberto Vitolo, Renata Walewska, Francesco Zaja, Thorsten Zenz, Pier Luigi Zinzani, Hossein Khiabanian, Arianna Calcinotto, Francesco Bertoni, Govind Bhagat, Elı́as Campo, Laurence de Leval, Stefan Dirnhofer, Stefano Pileri, Miguel Á. Piris, Alexandra Traverse‐Glehen, Alexandar Tzankov, Marco Paulli, Maurilio Ponzoni, Luca Mazzucchelli, Franco Cavalli, Emanuele Zucca, Davide Rossi - Blood 2021 被引用: 97